Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
State Street Industrial Select Sector SPDR ETF
XLI
$34.8B
| $8.79M | 0.01% |
127,900
+116,300
| +1,003% | +$7.54M |
|
|
MNTV
1302
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $8.75M | 0.01% |
371,700
-381,069
| -51% | -$6.95M |
|
1303
IES Holdings
IESC
$15B
| $8.73M | 0.01% |
376,832
+18,139
| +5% | +$379K |
|
|
BFIN
1304
DELISTED
BankFinancial
BFIN
| $8.72M | 0.01% |
1,038,505
-8,700
| -0.8% | -$69.6K |
|
1305
HCI Group
HCI
$2.3B
| $8.71M | 0.01% |
188,719
+48,100
| +34% | +$2.08M |
|
|
CORR
1306
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $8.69M | 0.01% |
949,635
-58,300
| -6% | -$734K |
|
1307
First Commonwealth Financial
FCF
$2.18B
| $8.67M | 0.01% |
1,047,000
-166,700
| -14% | -$1.41M |
|
1308
Hanmi Financial
HAFC
$964M
| $8.67M | 0.01% |
892,785
-21,100
| -2% | -$208K |
|
|
HMTV
1309
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $8.62M | 0.01% |
876,511
+40,511
| +5% | +$370K |
|
1310
Tompkins Financial
TMP
$1.45B
| $8.59M | 0.01% |
132,692
-44,800
| -25% | -$2.92M |
|
1311
Bank of Marin Bancorp
BMRC
$461M
| $8.59M | 0.01% |
257,811
-26,800
| -9% | -$849K |
|
1312
Ingles Markets
IMKTA
$1.66B
| $8.58M | 0.01% |
199,184
+89,100
| +81% | +$3.61M |
|
1313
Trinity Industries
TRN
$2.35B
| $8.57M | 0.01% |
+402,600
| New | +$7.75M |
|
1314
Lloyds Banking Group
LYG
$90.1B
| $8.57M | 0.01% |
5,711,900
-14,477,314
| -72% | -$21.7M |
|
|
CNH
1315
CNH Industrial
CNH
$16.8B
| $8.56M | 0.01% |
1,405,343
+238,049
| +20% | +$1.32M |
|
|
VAR
1316
DELISTED
Varian Medical Systems, Inc.
VAR
| $8.55M | 0.01% |
69,800
+23,500
| +51% | +$2.72M |
|
1317
Sensient Technologies
SXT
$5.54B
| $8.54M | 0.01% |
163,800
-137,300
| -46% | -$6.49M |
|
|
TPH
1318
DELISTED
Tri Pointe Homes
TPH
| $8.54M | 0.01% |
+581,336
| New | +$7.13M |
|
|
FNHC
1319
DELISTED
FedNat Holding Company Common Stock
FNHC
| $8.53M | 0.01% |
770,168
+29,163
| +4% | +$340K |
|
|
TPCO
1320
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $8.51M | 0.01% |
852,300
+30,500
| +4% | +$273K |
|
|
RDUS
1321
DELISTED
Radius Health, Inc.
RDUS
| $8.51M | 0.01% |
624,559
+39,200
| +7% | +$540K |
|
1322
Foster
FSTR
$406M
| $8.51M | 0.01% |
666,092
-42,300
| -6% | -$544K |
|
1323
Semtech
SMTC
$12.8B
| $8.49M | 0.01% |
162,600
-178,100
| -52% | -$8.33M |
|
1324
SiriusPoint
SPNT
$2.72B
| $8.49M | 0.01% |
1,130,579
-254,200
| -18% | -$1.92M |
|
1325
Peapack-Gladstone Financial
PGC
$822M
| $8.49M | 0.01% |
453,220
-63,920
| -12% | -$1.13M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.